Abstract:Background: There is a scarcity of prospective studies investigating the relative roles of skin prick and intradermal testing, serum-specific Immunoglobulin E, and extended oral challenges in diagnosing children with reported beta-lactam allergies. Objective: To determine the sensitivity and specificity of skin testing and serum-specific Immunoglobulin E in children with beta-lactam allergies, with immediate and non-immediate historic reactions. Methods: Four hundred children with parent-reported beta-lactam allergies were recruited into an open-label prospective study. Detailed allergy histories were collected. Those with medically observed and documented histories of anaphylaxis, requiring epinephrine, or SCARs were excluded. In total, 380 children underwent all testing modalities and a direct provocation test. Each child was followed up for a minimum of three years. Results: True allergy in children was uncommon, 8·3% reacted to the direct provocation challenge or the 5-day extended oral provocation challenge. Children reporting cephalosporin allergy or a reaction within one year were more likely to react to direct provocation testing. The sensitivity, specificity, and positive predictive value of skin testing was 12·5%, 98·8% and 20·0% for direct challenge outcomes, 4·76%, 99·0% and 25·0% for extended challenge outcomes, and 6·9%, 99·0% and 40·0% for both challenges combined. Follow-up investigations revealed that 5·7% of children had a mild repeat reaction and 2·7% continued to avoid the culprit despite successful delabeling. The relabeling rate for children readmitted to hospital was 15% with the relabeing being unfounded. Conclusion: Genuine beta-lactam allergies were rare, with over 90% of children effectively delabeled. Skin and serum-specific Immunoglobulin E testing did not aid the diagnosis of beta-lactam antibiotic allergy in children, regardless of medical history. Extended oral challenges proved valuable in confirming allergies and boosted parental confidence.

Serum specific IgE antibodies in immediate drug hypersensitivity

Antibiotic allergies in children and adults: from clinical symptoms to skin testing diagnosis

Perioperative Hypersensitivity Reactions: Diagnosis, Treatment and Evaluation

Non-IgE-mediated drug-induced hypersensitivity reactions in pediatrics

IgE antibodies in occupational asthma: are they causative or an associated phenomenon?

Non-IgE-Mediated Drug Hypersensitivity Reactions

Comparative Performance of 4 Penicillin-Allergy Prediction Strategies in a Large Cohort

Molecular allergy diagnosis: status anno 2015

Early testing and grade of the reaction are affecting factors of skin test positivity in β-Lactam allergies

Comparing skin and serum testing to direct challenge outcomes in children with beta-lactam allergies

In vitro diagnostics of drug allergies

Drug allergy in primary care: systematic review to support quality improvement initiative of management and optimization of healthcare pathways

Serum MRGPRX2 as a Long-term Biomarker for Iodinated Contrast Media-Induced Anaphylaxis

Drug hypersensitivity reactions: review of the state of the science for prediction and diagnosis

Tryptase in drug-induced anaphylaxis: the need for acute and baseline values

Beta-lactam-induced immediate hypersensitivity reactions: A genome-wide association study of a deeply phenotyped cohort

Cephalosporin Allergy: Updates on Diagnostic Testing

Role and interpretation of total serum IgE measurements in the diagnosis of allergic airway disease in adults

Identifying patients at risk of anaphylaxis

Detection of specific immunoglobulin E antibodies toward common airborne allergens, peanut, wheat, and latex in solvent/detergent-treated pooled plasma

The Natural History of IgE-Mediated Food Allergy: Can Skin Prick Tests and Serum-Specific IgE Predict the Resolution of Food Allergy?